From the Food and Drug Administration.
Nightingale
S L
SL
D056486:Chemical and Drug Induced Liver Injury; D002753:Chlorzoxazone / Q000009:adverse effects*; D003195:Computer Communication Networks; D004348:Drug Labeling; D006801:Humans; D009125:Muscle Relaxants, Central / Q000009:adverse effects*; D010353:Patient Education as Topic; D011367:Professional Staff Committees / Q000458:organization & administration*; D014481:United States; D014486:United States Food and Drug Administration
D009125:Muscle Relaxants, Central; D002753:Chlorzoxazone